Search

Anthelmintic resistance in sheep parasitic gastrointestinal nematodes is widespread and a severe health and economic issue but prevalence of resistance and involved parasite species are unknown in Germany. Here, the faecal egg count reduction test (FECRT) was performed on eight farms using fenbendazole, ivermectin and moxidectin and on four farms using only moxidectin. A questionnaire was used to obtain data on management practices to potentially identify risk factors for presence of resistance. All requirements of the recently revised WAAVP guideline for diagnosing anthelmintic resistance using the FECRT were applied. Nematode species composition in pre- and post-treatment samples was analysed with the nemabiome approach. Using the eggCounts statistic package, resistance against fenbendazole, ivermectin and moxidectin was found on 7/8, 8/8 and 8/12 farms, respectively. No formal risk factor analysis was conducted since resistance was present on most farms. Comparison with the bayescount R package results revealed substantial agreement between methods (Cohen's κ = 0.774). In contrast, interpretation of data comparing revised and original WAAVP guidelines resulted in moderate agreement (Cohen's κ = 0.444). The FECR for moxidectin was significantly higher than for ivermectin and fenbendazole. Nemabiome data identified 4 to 12 species in pre-treatment samples and treatments caused a small but significant decrease in species diversity (inverse Simpson index). Non-metric multidimensional scaling and k-means clustering were used to identify common patterns in pre- and post-treatment samples. However, post-treatment samples were scattered among the pre-treatment samples. Resistant parasite species differed between farms. In conclusion, the revised FECRT guideline allows robust detection of anthelmintic resistance. Resistance was widespread and involved multiple parasite species. Resistance against both drug classes on the same farm was common. Further studies including additional drugs (levamisole, monepantel, closantel) should combine sensitive FECRTs with nemabiome data to comprehensively characterise the anthelmintic susceptibility status of sheep nematodes in Germany., Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Georg von Samson-Himmelstjerna (GvSH) reports financial support was provided by Federal Office of Consumer Protection and Food Safety, Berlin, Germany. GvSH is a member of the editorial board of Int. J. Parasitol. Drugs Drug Rest. Furthermore, he declares that he has previous and ongoing research and consultancy collaborations with several veterinary pharmaceutical and diagnostic companies., (Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.)

Introduction: To evaluate the clinical outcome of cartilage-bone-transplantations of the knee in patients with different indications, we studied the clinical results of 45 patients with a follow-up of 24 months after operation., Patients and Methods: 29 male and 16 female patients with a mean age of 37.7 yrs (16-58 yrs) were included. Indications for operation were osteochondritis dissecans (OD) (n=13), limited arthritis (n=20), traumatic lesions (n=5) and retropatellar lesions (n=7). The results were evaluated by clinical score (McDermott Score; preoperatively, and 3, 6, 12, 24 months postoperatively), magnetic resonance imaging, and re-arthroscopy for most patients., Results: 42 of 45 patients judged the operation as successful. The mean score value of all patients raised from 66.3 pts (out of 100 pts) preoperatively to 92.7 pts 24 months postoperatively. The results of the patients with circumscript arthritic lesions (62.9 pts. preoperatively vs. 91.5 pts. postoperatively) were comparable to those of the other patients., Conclusion: We conclude that cartilage-bone-transplantation of the knee is a valuable procedure to improve joint function not only after OD or trauma, but also in joints with local arthritic lesions on condition that there is an adequate quality of the donor site.